Featured Research

from universities, journals, and other organizations

Telehealth unlikely to be cost effective for patients with long term conditions, study finds

Date:
March 21, 2013
Source:
BMJ-British Medical Journal
Summary:
Telehealth does not seem to be a cost effective addition to standard support and treatment for patients with long term conditions, a new study finds

Telehealth does not seem to be a cost effective addition to standard support and treatment for patients with long term conditions, finds a study published on bmj.com today.

The findings follow a BMJ study published last month showing that telehealth does not improve quality of life for patients with long term conditions.

Telehealth uses technology to help people with health problems live more independently at home. For example, blood pressure or blood glucose levels can be measured at home and electronically transmitted to a health professional, reducing the need for hospital visits.

Telehealth has been promoted to reduce healthcare costs while improving health related quality of life, but there is very little good quality evidence on the effect of telehealth on service use and costs.

So, a team of UK researchers examined the costs and cost effectiveness of telehealth compared with usual care over 12 months in 965 patients with a long term condition (heart failure, COPD or diabetes).

The study is part of the Whole Systems Demonstrator Trial -- one of the largest and most comprehensive investigations of telehealth and telecare ever conducted.

Of the 965 patients, 534 received telehealth equipment and support, while 431 received usual care. The results took account of costs to both health and social care systems.

The cost per quality adjusted life year (QALY) -- a combined measure of quantity and quality of life -- of telehealth when added to usual care was 92,000. This is well above the cost effectiveness threshold of 30,000 set by the UK National Institute for Health and Clinical Excellence (NICE). The probability of cost effectiveness was low (11%).

Even when the effects of equipment price reductions and increased working capacity of services were combined, the probability that telehealth is cost effective was only about 61%, at a threshold of 30 000 per QALY.

The authors say that the QALY gain by people using telehealth in addition to standard support and treatment was similar to those receiving usual care, and total costs for the telehealth group were higher. As such they conclude that "telehealth does not seem to be a cost effective addition to standard support and treatment."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. Henderson, M. Knapp, J.-L. Fernandez, J. Beecham, S. P. Hirani, M. Cartwright, L. Rixon, M. Beynon, A. Rogers, P. Bower, H. Doll, R. Fitzpatrick, A. Steventon, M. Bardsley, J. Hendy, S. P. Newman. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ, 2013; 346 (mar20 4): f1035 DOI: 10.1136/bmj.f1035

Cite This Page:

BMJ-British Medical Journal. "Telehealth unlikely to be cost effective for patients with long term conditions, study finds." ScienceDaily. ScienceDaily, 21 March 2013. <www.sciencedaily.com/releases/2013/03/130321205641.htm>.
BMJ-British Medical Journal. (2013, March 21). Telehealth unlikely to be cost effective for patients with long term conditions, study finds. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2013/03/130321205641.htm
BMJ-British Medical Journal. "Telehealth unlikely to be cost effective for patients with long term conditions, study finds." ScienceDaily. www.sciencedaily.com/releases/2013/03/130321205641.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins